Pharmaceuticals

Inhalation Anesthesia Industry Forecast to Hit $2.29 Billion by 2029 With a Strong 8.8% CAGR

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Inhalation Anesthesia Market Size During 2025–2029?

The inhalation anesthesia market has seen substantial expansion in recent years. It is anticipated to expand from $1.54 billion in 2024 to $1.64 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to a rise in surgical procedures demanding anesthesia, an expanding geriatric population, the innovation of inhalation anesthetics, the proliferation of ambulatory surgical centers, and an increased incidence of chronic illnesses such as heart disease and cancer.

The inhalation anesthesia market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $2.29 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the forecast period include an increasing need for minimally invasive surgeries, rising global healthcare spending, a greater volume of surgical procedures in developing markets, the application of inhalation anesthesia in veterinary medicine, and enhanced government funding for research and development of novel inhalation anesthetics. Key developments expected in the forecast period encompass advancements in anesthesia delivery system technology, the creation of inhalation anesthesia devices for pediatric patients, a move towards sevoflurane and desflurane usage, an emphasis on environmentally friendly anesthetic agents, and the incorporation of monitoring technologies into anesthesia delivery.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp

What Are The Drivers Pushing New Developments In The Inhalation Anesthesia Market?

The expanding elderly demographic is projected to stimulate the growth of inhalation anesthesia throughout the forecast period. This increasing geriatric population is fueling the inhalation anesthesia market due to their elevated susceptibility to degenerative and chronic illnesses, which consequently leads to a greater number of surgeries and therapies. Moreover, the rising geriatric population’s heightened proneness to conditions such as cardiovascular, neurological, respiratory, and degenerative disorders is boosting market expansion. It is often challenging to administer anesthesia via an intravenous route to elderly patients because of fragile blood vessels and difficulties with patient compliance. For instance, in October 2022, the World Health Organization, a Switzerland-based international public health organization, reported that the global population of individuals aged 60 years was expected to increase to 1.4 billion by 2022, compared to 1 billion in 2020. Furthermore, by 2030, it is anticipated that 1 out of 6 people worldwide will be aged 60 years or older. Therefore, the growing geriatric population is anticipated to drive demand for inhalation anesthesia during the forecast period.

Which Key Segments Fueling The Inhalation Anesthesia Market?

The inhalation anesthesia market covered in this report is segmented –

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide

2) By Application: Induction, Maintenance

3) By End User: Hospitals, Ambulatory Surgical Centers

Subsegments:

1) By Sevoflurane: Liquid Form, Gas Form

2) By Desflurane: Liquid Form, Gas Form

3) By Isoflurane: Liquid Form, Gas Form

4) By Nitrous Oxide: Medical-Grade Nitrous Oxide, Industrial-Grade Nitrous Oxide

Which Ongoing Trends Are Expected To Shape The Inhalation Anesthesia Market Outlook?

Companies operating in the field of inhalation anesthesia are developing innovative products such as Sedaconda to address industry requirements and bolster their global market standing. Sedaconda functions as an inhaled sedation therapy, administered with the Anaesthetic Conserving Device (ACD), and is sanctioned for use in intensive care. For example, in February 2022, Sedana Medical AB, a Sweden-based med tech and pharmaceutical company, launched Sedaconda (isoflurane) in the German market. Sedaconda (isoflurane) is delivered via the medical device called Sedaconda ACD (Anaesthetic Conserving Device) and represents the sole approved inhaled sedation therapy authorized for application in intensive care settings. Following its European DCP approval in July 2021, Sedaconda (isoflurane) has secured national approvals in 14 countries.

Which Major Industry Participants Are Leading The Inhalation Anesthesia Market Growth?

Major companies operating in the inhalation anesthesia market include Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

What Are The Key Regional Factors Influencing The Inhalation Anesthesia Market Growth?

North America was the largest region in the inhalation anesthesia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Inhalation Anesthesia Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7198&type=smp

Browse Through More Reports Similar to the Global Inhalation Anesthesia Market 2025, By The Business Research Company

Anesthetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anesthetics-global-market-report

Inhalation Sedative Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inhalation-sedative-global-market-report

Central Nervous System Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795